PetMed Express Inc PETS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
PetMed Express, Inc. Announces Appointment of Robyn D’Elia as Chief Financial Officer
-
PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
PetMeds® Announces Fiscal 2025 First Quarter Financial Results
-
PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer
-
PetMed Express, Inc. Sets Fiscal First Quarter 2025 Earnings Call
-
PetMed's stock plunges to 19-year low as dividend yield to drop from 19% to zero
Trading Information
- Previous Close Price
- $3.55
- Day Range
- $3.57–3.68
- 52-Week Range
- $2.90–11.20
- Bid/Ask
- $3.63 / $3.64
- Market Cap
- $74.99 Mil
- Volume/Avg
- 110,946 / 309,358
Key Statistics
- Price/Earnings (Normalized)
- 78.26
- Price/Sales
- 0.27
- Dividend Yield (Trailing)
- 8.45%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 8.45%
Company Profile
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Small Value
- Total Number of Employees
- 287
- Website
- https://www.petmeds.com
Comparables
Valuation
|
Metric
|
PETS
|
301498
|
001222
|
|---|---|---|---|
Price/Earnings (Normalized) | 78.26 | 40.38 | 16.21 |
Price/Book Value | 0.78 | 5.37 | 1.71 |
Price/Sales | 0.27 | 4.38 | 1.90 |
Price/Cash Flow | 31.12 | 41.47 | 11.32 |
Price/Earnings
PETS
301498
001222
Financial Strength
|
Metric
|
PETS
|
301498
|
001222
|
|---|---|---|---|
Quick Ratio | 0.83 | 2.78 | 4.05 |
Current Ratio | 1.33 | 4.37 | 5.59 |
Interest Coverage | — | — | 305.07 |
Quick Ratio
PETS
301498
001222
Profitability
|
Metric
|
PETS
|
301498
|
001222
|
|---|---|---|---|
Return on Assets (Normalized) | −3.26% | 15.54% | 8.42% |
Return on Equity (Normalized) | −5.22% | 18.10% | 10.70% |
Return on Invested Capital (Normalized) | −5.75% | 17.50% | 8.22% |
Return on Assets
PETS
301498
001222
Pharmaceutical Retailers Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Raia Drogasil SA ADR
RADLY
| — | Scllydc | $8.2 Bil | |||
| Alibaba Health Information Technology Ltd ADR
ALBBY
| — | Frsjyjx | $7.3 Bil | |||
| Alibaba Health Information Technology Ltd
ALBHF
| — | Whvtgd | $7.3 Bil | |||
| Walgreens Boots Alliance Inc
WBA
| Yddh | Gkxl | $7.1 Bil | |||
| Clicks Group Ltd ADR
CLCGY
| — | Tpygh | $5.5 Bil | |||
| COSMOS Pharmaceutical Corp
CSMYF
| — | Bgcdbr | $4.0 Bil | |||
| Tsuruha Holdings Inc
TSUSF
| — | Jlgrqd | $3.0 Bil | |||
| Redcare Pharmacy NV ADR
SAEYY
| — | Xmzttdh | $2.9 Bil | |||
| DocMorris AG
ZRSEF
| — | Jzsfz | $523.8 Mil | |||
| High Tide Inc
HITI
| — | Gzbg | $161.7 Mil |
United States